These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 14011852)

  • 1. [Effect of the intensity of the radiation dose on the incidence formation of hematopoietic system neoplasms in mice].
    ALEKSANDROV SN; GALKOVSKAIA KF
    Vopr Onkol; 1963; 9(3)():40-4. PubMed ID: 14011852
    [No Abstract]   [Full Text] [Related]  

  • 2. RELATION OF RADIATION DOSE RATE TO INCIDENCE OF NEOPLASMS IN MOUSE HEMATOPOIETIC ORGANS.
    ALEKSANDROV SN; GALKOVSKAYA KF
    Fed Proc Transl Suppl; 1964; 23():59-61. PubMed ID: 14112008
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematopoietic tissue neoplasms in animals administered 90Sr.
    McClellan RO
    Health Phys; 1966 Sep; 12(9):1362-5. PubMed ID: 5339372
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumours of the haematopoietic system.
    Barthold SW
    IARC Sci Publ; 1996; (126):365-83. PubMed ID: 8875276
    [No Abstract]   [Full Text] [Related]  

  • 6. Family history of hematopoietic and non-hematopoietic malignancies and risk of non-Hodgkin lymphoma.
    Zhang Y; Wang R; Holford TR; Leaderer B; Zahm SH; Boyle P; Zhu Y; Qin Q; Zheng T
    Cancer Causes Control; 2007 May; 18(4):351-9. PubMed ID: 17206533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
    Friedberg JW
    Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
    [No Abstract]   [Full Text] [Related]  

  • 8. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caloric restriction prevents radiation-induced myeloid leukemia in C3H/HeMs mice and inversely increases incidence of tumor-free death: implications in changes in number of hemopoietic progenitor cells.
    Yoshida K; Hirabayashi Y; Watanabe F; Sado T; Inoue T
    Exp Hematol; 2006 Mar; 34(3):274-83. PubMed ID: 16543061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers.
    van Kempen-Harteveld ML; Brand R; Kal HB; Verdonck LF; Hofman P; Schattenberg AV; van der Maazen RW; Cornelissen JJ; Eijkenboom WM; van der Lelie JP; Oldenburger F; Barge RM; van Biezen A; Vossen JM; Noordijk EM; Struikmans H
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1444-54. PubMed ID: 18294781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma.
    Bhatia R; Van Heijzen K; Palmer A; Komiya A; Slovak ML; Chang KL; Fung H; Krishnan A; Molina A; Nademanee A; O'Donnell M; Popplewell L; Rodriguez R; Forman SJ; Bhatia S
    J Clin Oncol; 2005 Sep; 23(27):6699-711. PubMed ID: 16170178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
    Hodgson DC; Koh ES; Tran TH; Heydarian M; Tsang R; Pintilie M; Xu T; Huang L; Sachs RK; Brenner DJ
    Cancer; 2007 Dec; 110(11):2576-86. PubMed ID: 17941006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.
    Phillips GL; Meisenberg BR; Reece DE; Adams VR; Badros AZ; Brunner JL; Fenton RG; Filicko J; Grosso DL; Hale GA; Howard DS; Johnson VP; Kniska A; Marshall KW; Mookerjee B; Nath R; Rapoport AP; Sarkodee-Adoo C; Takebe N; Vesole DH; Wagner JL; Flomenberg N
    Bone Marrow Transplant; 2004 Apr; 33(8):781-7. PubMed ID: 14767498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks.
    Shuryak I; Sachs RK; Hlatky L; Little MP; Hahnfeldt P; Brenner DJ
    J Natl Cancer Inst; 2006 Dec; 98(24):1794-806. PubMed ID: 17179481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Existence of a threshold-like dose for gamma-ray induction of thymic lymphomas and no susceptibility to radiation-induced solid tumors in SCID mice.
    Ishii-Ohba H; Kobayashi S; Nishimura M; Shimada Y; Tsuji H; Sado T; Ogiu T
    Mutat Res; 2007 Jun; 619(1-2):124-33. PubMed ID: 17397880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultraviolet radiation exposure and risk of malignant lymphomas.
    Smedby KE; Hjalgrim H; Melbye M; Torrång A; Rostgaard K; Munksgaard L; Adami J; Hansen M; Porwit-MacDonald A; Jensen BA; Roos G; Pedersen BB; Sundström C; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Feb; 97(3):199-209. PubMed ID: 15687363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based research on occupational and environmental factors for leukemia and non-Hodgkin's lymphoma: the Northern Germany Leukemia and Lymphoma Study (NLL).
    Hoffmann W; Terschüeren C; Heimpel H; Feller A; Butte W; Hostrup O; Richardson D; Greiser E
    Am J Ind Med; 2008 Apr; 51(4):246-57. PubMed ID: 18270999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic radiation for lymphoma: risk of malignant mesothelioma.
    Teta MJ; Lau E; Sceurman BK; Wagner ME
    Cancer; 2007 Apr; 109(7):1432-8. PubMed ID: 17315168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later.
    Lazarus HM; Phillips GL; Herzig RH; Hurd DD; Wolff SN; Herzig GP
    J Clin Oncol; 2008 May; 26(14):2240-3. PubMed ID: 18467711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.